005", "section_type": "REF", "source": "Endocrinol. Metab. Clin. N. Am.", "type": "ref", "volume": "34", "year": "2005"}, "text": "Potential cardiovascular benefits of insulin sensitizers", "sentences": [], "annotations": [], "relations": []}, {"offset": 40873, "infons": {"fpage": "e000205", "name_0": "surname:McCarty;given-names:M.F.", "name_1": "surname:DiNicolantonio;given-names:J.J.", "pub-id_doi": "10.1136/openhrt-2014-000205", "pub-id_pmid": "25685364", "section_type": "REF", "source": "Open Heart", "type": "ref", "volume": "2", "year": "2015"}, "text": "Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1", "sentences": [], "annotations": [], "relations": []}, {"offset": 41003, "infons": {"fpage": "203", "lpage": "216", "name_0": "surname:Nauck;given-names:M.", "pub-id_doi": "10.1111/dom.12591", "pub-id_pmid": "26489970", "section_type": "REF", "source": "Diabetes Obes. Metab.", "type": "ref", "volume": "18", "year": "2016"}, "text": "Incretin therapies: Highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors", "sentences": [], "annotations": [], "relations": []}, {"offset": 41174, "infons": {"fpage": "854", "lpage": "859", "name_0": "surname:Mikhail;given-names:N.", "pub-id_doi": "10.4239/wjd.v5.i6.854", "pub-id_pmid": "25512787", "section_type": "REF", "source": "World J. Diabetes", "type": "ref", "volume": "5", "year": "2014"}, "text": "Place of sodium-glucose co-transporter type 2 inhibitors for treatment of type 2 diabetes", "sentences": [], "annotations": [], "relations": []}, {"offset": 41264, "infons": {"fpage": "4645", "lpage": "4654", "name_0": "surname:Cooper;given-names:M.S.", "name_1": "surname:Stewart;given-names:P.M.", "pub-id_doi": "10.1210/jc.2009-1412", "pub-id_pmid": "19837912", "section_type": "REF", "source": "J. Clin. Endocrinol. Metab.", "type": "ref", "volume": "94", "year": "2009"}, "text": "11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation", "sentences": [], "annotations": [], "relations": []}, {"offset": 41401, "infons": {"fpage": "S13", "lpage": "S18", "name_0": "surname:Schleicher;given-names:E.D.", "name_1": "surname:Weigert;given-names:C.", "pub-id_doi": "10.1046/j.1523-1755.2000.07703.x", "section_type": "REF", "source": "Kidney Int.", "type": "ref", "volume": "58", "year": "2000"}, "text": "Role of the hexosamine biosynthetic pathway in diabetic nephropathy", "sentences": [], "annotations": [], "relations": []}, {"offset": 41469, "infons": {"fpage": "1415", "lpage": "1422", "name_0": "surname:Stull;given-names:A.J.", "name_1": "surname:Wang;given-names:Z.Q.", "name_2": "surname:Zhang;given-names:X.H.", "name_3": "surname:Yu;given-names:Y.", "name_4": "surname:Johnson;given-names:W.D.", "name_5": "surname:Cefalu;given-names:W.T.", "pub-id_doi": "10.2337/db11-0744", "pub-id_pmid": "22474028", "section_type": "REF", "source": "Diabetes", "type": "ref", "volume": "61", "year": "2012"}, "text": "Skeletal muscle protein tyrosine phosphatase 1B regulates insulin sensitivity in African Americans", "sentences": [], "annotations": [], "relations": []}, {"offset": 41568, "infons": {"elocation-id": "e90344", "name_0": "surname:Fernandez-Ruiz;given-names:R.", "name_1": "surname:Vieira;given-names:E.", "name_2": "surname:Garcia-Roves;given-names:P.M.", "name_3": "surname:Gomis;given-names:R.", "pub-id_doi": "10.1371/journal.pone.0090344", "pub-id_pmid": "24587334", "section_type": "REF", "source": "PLoS ONE", "type": "ref", "volume": "9", "year": "2014"}, "text": "Protein tyrosine phosphatase-1B modulates pancreatic beta-cell mass", "sentences": [], "annotations": [], "relations": []}, {"offset": 41636, "infons": {"fpage": "1239", "lpage": "1258", "name_0": "surname:Qian;given-names:S.", "name_1": "surname:Zhang;given-names:M.", "name_2": "surname:He;given-names:Y.", "name_3": "surname:Wang;given-names:W.", "name_4": "surname:Liu;given-names:S.", "pub-id_doi": "10.4155/fmc-2016-0064", "pub-id_pmid": "27357615", "section_type": "REF", "source": "Future Med. Chem.", "type": "ref", "volume": "8", "year": "2016"}, "text": "Recent advances in the development of protein tyrosine phosphatase 1B inhibitors for Type 2 diabetes", "sentences": [], "annotations": [], "relations": []}, {"offset": 41737, "infons": {"fpage": "199", "lpage": "212", "name_0": "surname:Rusu;given-names:V.", "name_1": "surname:Hoch;given-names:E.", "name_2": "surname:Mercader;given-names:J.M.", "name_3": "surname:Tenen;given-names:D.E.", "name_4": "surname:Gymrek;given-names:M.", "name_5": "surname:Hartigan;given-names:C.R.", "name_6": "surname:DeRan;given-names:M.", "name_7": "surname:von Grotthuss;given-names:M.", "name_8": "surname:Fontanillas;given-names:P.